sellWeak
Mohideen Pharis sold $510 of DBVT
Chief Medical Officer at DBV Technologies S.A.. 600 shares at an average of $0.85, traded Jan 30, 2025, filed Jan 31, 2025.
Warning score
15Value
$510
600 shares
Holdings after
110,510
-1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-25-002509, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 30, 2025 | SOpen-market sale Ordinary Shares | -600 | $0.85 | $510 | 110,510 | Jan 31, 2025 |
Related signals
Other insiders at DBV Technologies S.A. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 15Weak | sell | DBVT DBV Technologies S.A. | Mohideen Pharis Chief Medical Officer | $503 | 907 | |
| 15Weak | sell | DBVT DBV Technologies S.A. | Mohideen Pharis Chief Medical Officer | $1,269 | 2,350 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.